Regencell Bioscience
13 hedge funds and large institutions have $11.8M invested in Regencell Bioscience in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+8
Holders Change %
+160%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.25M |
| 2 |
Squarepoint
New York
|
+$1.7M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$888K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$768K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$639K |
Top Sellers
| 1 |
BlackRock
New York
|
-$88.7K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$30K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$22.3K |
